Lymphocyte gene therapy

Human Gene Therapy

Volumn 2, Issue 2, 1991, Pages 107-109

  Culver, Kenneth W ^a   Anderson, W French ^a   Blaese, R Michael ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADA;

ADENOSINE DEAMINASE;

ARTICLE; CELL CULTURE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; ENZYMOLOGY; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; NUTRITIONAL DEFICIENCY; T LYMPHOCYTE; TRANSPLANTATION;

ADENOSINE DEAMINASE; CELLS, CULTURED; CHILD; CLINICAL PROTOCOLS; GENE THERAPY; HUMAN; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TRANSFECTION;

EID: 0026176988     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1991.2.2-107     Document Type: Article

References (13)

1. BLAESE, R.M., CULVER, K.W., and ANDERSON, W.F. (1990). The ADA human gene therapy clinical protocol. Hum. Gene Ther. 1, 331-362.
2. CULVER, K.W., FREEMAN, S.F., KOHN, D., WOOD, M., ANDERSON, W.F., BERZOFSKY, J.A., and BLAESE, R.M. (1988). Retroviral-mediated gene transfer into cultured lymphoid cells as a vehicle for gene therapy. J. Cell Biochem. Suppl. 12B, 1, 171.
3. CULVER, K.W., OSBORNE, W.R.A., MILLER, A.D., FLEISHER, T.A., BERGER, M., ANDERSON, W.F., and BLAESE, R.M. (1991a). Correction of ADA deficiency in human T-lymphocytes using retroviral-mediated gene transfer. Transpl. Proc. 23, 170-171.
4. CULVER, K.W., MORGAN, R.A., OSBORNE, W.R.A., LEE, R.T., LENSCHOW, D., ABLE, C., CORNETTA, K., MILLER, A.D., ANDERSON, W.F., and BLAESE, R.M. (1991b). In vivo expression and survival of gene-modified Rhesus T lymphocytes. Hum. Gene Ther. 1, 399-410.
5. CULVER, K., CORNETTA, K., MORGAN, R., MORECKI, S., ABERSOLD, P., KASID, A., LOTZE, M., ROSENBERG, S.A., ANDERSON, W.F., and BLAESE, R.M. (1991c). Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc. Natl. Acad. Sci. USA 88, 3155-3159.
6. FERRARI, G., ROSSINI, S., GIAVAZZI, R., MAGGIONI, D., NOBILI, N., SOLDATI, M., UNGERS, G., MAVILIO, F., GILBOA, E., and BORDIGNON, C. (1991). An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science 251, 1363-1366.
7. GIBLETT, E.R., ANDERSON, J.E., COHEN, F., POLLARA, B., and MEUWISSEN, H.J. (1972). Adenosine deaminase deficiency in two patients with severely impaired cellular immunodeficiency. Lancet ii, 1067-1069.
8. GILBOA, E., EGLITIS, M.A., KANTOFF, P.W., and ANDERSON, W.F. (1986). Transfer and expression of cloned genes using retroviral vectors. Biotechniques 4, 504-512.
9. HERSHFIELD, M.S., BUCKLEY, R.H., GREENBERG, M.L., MELTON, A.L., SCHIFF, R., HATEM, C., KURTZBERG, J., MARKERT, M.L., KOBAYASHI, R.H., KOBAYASHI, A.L., and ABUCHOWSKI, A. (1987). Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N. Engl. J. Med. 316, 589-596.
10. KEEVER, C.A., FLOMENBERG, N., BRUCHSTEIN, J., SULLIVAN, M., COLLINS, .N.H., BURNS, J., DUPONT, B., and O'REILLY, R.J. (1988). Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clin. Immunol. Immunopath. 48, 261-276.
11. LEVY, Y., HERSHFIELD, M.S., FERNANDEZ-MEJIA, C., POLMAR, S.H., SCUDIERY, D., BERGER, M., and SORENSEN, R.U. (1988). Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycolmodified adenosine deaminase. J. Pediatr. 113, 312-317.
12. O'REILLY, R.J., KEEVER, C.A., SMALL, T.N., and BRUCHSTEIN, J. (1989). The use of HLA-non-identical T-cell-depleted marrow transplants for the correction of severe combined immunodeficiency disease. Immunodeficiency Rev. 1, 273-309.
13. WILLIAMS, D.A. (1990). Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer. Hum. Gene Ther. 1, 229-239.